These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2646089)

  • 21. Double blind study on the efficacy and safety of tetrabamate and chlordiazepoxide in the treatment of the acute alcohol withdrawal syndrome.
    Radouco-Thomas S; Garcin F; Guay D; Marquis PA; Chabot F; Huot J; Chawla S; Forest JC; Martin S; Stewart G
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):55-75. PubMed ID: 2664886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term detoxification with methadone.
    Senay EC; Dorus W; Showalter CV
    Ann N Y Acad Sci; 1981; 362():203-16. PubMed ID: 7020530
    [No Abstract]   [Full Text] [Related]  

  • 23. Low (40 mg) versus high (80 mg) dose methadone in a 180-day heroin detoxification program.
    Banys P; Tusel DJ; Sees KL; Reilly PM; Delucchi KL
    J Subst Abuse Treat; 1994; 11(3):225-32. PubMed ID: 8072050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind trial of alprazolam and chlordiazepoxide in the management of the acute ethanol withdrawal syndrome.
    Wilson A; Vulcano BA
    Alcohol Clin Exp Res; 1985; 9(1):23-7. PubMed ID: 3887964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonidine vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome.
    Baumgartner GR; Rowen RC
    Arch Intern Med; 1987 Jul; 147(7):1223-6. PubMed ID: 3300587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
    Negus SS
    J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug substitution in heroin dependence with methadone].
    Krausz M; Raschke P; Naber D
    Internist (Berl); 1999 Jun; 40(6):645-50. PubMed ID: 10420320
    [No Abstract]   [Full Text] [Related]  

  • 29. A randomized double-blind study of neuroelectric therapy in opiate and cocaine detoxification.
    Gariti P; Auriacombe M; Incmikoski R; McLellan AT; Patterson L; Dhopesh V; Mezochow J; Patterson M; O'Brien C
    J Subst Abuse; 1992; 4(3):299-308. PubMed ID: 1458046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid detoxification from opioid dependence under general anaesthesia versus standard methadone tapering: abstinence rates and withdrawal distress experiences.
    Krabbe PF; Koning JP; Heinen N; Laheij RJ; van Cauter RM; De Jong CA
    Addict Biol; 2003 Sep; 8(3):351-8. PubMed ID: 13129838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
    Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
    J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of methadone versus methadone and guanfacine in the detoxification of heroin-addicted patients.
    San L; Fernandez T; Cami J; Gossop M
    J Subst Abuse Treat; 1994; 11(5):463-9. PubMed ID: 7869468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper.
    Epstein DH; Preston KL
    Am J Addict; 2015 Jun; 24(4):323-8. PubMed ID: 25846329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early clinical studies of levo-alpha acetylmethadol (LAAM): an opiate for use in the medical treatment of chronic heroin dependence.
    Blaine JD
    NIDA Res Monogr; 1978; (19):249-59. PubMed ID: 106289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: lofexidine is not a useful adjunct to chlordiazepoxide.
    Keaney F; Strang J; Gossop M; Marshall EJ; Farrell M; Welch S; Hahn B; Gonzalez A
    Alcohol Alcohol; 2001; 36(5):426-30. PubMed ID: 11524309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Withdrawal from methadone maintenance. Rate of withdrawal and expectation.
    Senay EC; Dorus W; Goldberg F; Thornton W
    Arch Gen Psychiatry; 1977 Mar; 34(3):361-7. PubMed ID: 843188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
    Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
    Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts.
    Bickel WK; Stitzer ML; Bigelow GE; Liebson IA; Jasinski DR; Johnson RE
    Clin Pharmacol Ther; 1988 Jan; 43(1):72-8. PubMed ID: 3275523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transferring methadone-maintained outpatients to the buprenorphine sublingual tablet: a preliminary study.
    Greenwald MK; Schuh KJ; Stine SM
    Am J Addict; 2003; 12(4):365-74. PubMed ID: 14504028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Methadone, clonidine and levomepromazine in the treatment of opiate abstinence syndrome: double-blind clinical trial in heroin-addicted patients admitted to a general hospital for organic pathology].
    Vilalta J; Treserra J; García-Esteve L; García-Giralt M; Cirera E
    Med Clin (Barc); 1987 May; 88(17):674-6. PubMed ID: 3613695
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.